A Study to Find Out if Daridorexant is Safe and Efficacious in Patients With Insomnia and Comorbid Nocturia

NCT05597020 PHASE4 COMPLETED Results posted

A study to find out if daridorexant is safe and efficacious in patients with insomnia and comorbid nocturia

Details

Lead sponsor	Idorsia Pharmaceuticals Ltd.
Phase	PHASE4
Status	COMPLETED
Enrolment	60
Start date	Thu Feb 16 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Thu Apr 18 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Insomnia Disorder
• Nocturia

Interventions

• Daridorexant
• Placebo

Countries

United States, Germany, Spain